Skip to content

NOLCA MED

Active Private limited companyfounded 2022active for 3 yearsFaubourg de Namur 82, 1400 NivellesKBO/BCE: BE 0794.997.746

Lifetime

4 annual accounts with figures on one time axis
peak of €21,269 in 2024
€20,616▼ 3.1%
peak of €9,022 in 2024
€8,260▼ 8.4%
peak of €18,959 in 2024
€2,000▼ 89.5%
€29,081▲ 669%
Board1 name since 2022
1 director
Documentsfilings and deeds
18-08-202618 days late
2025micro format
Dividend €25,218Equity from €18,959 to €2,000Debts from €3,780 to €29,081Cash from €2,636 to €13,740

Key points

from the 2025 annual accounts

Equity

€2,000 ▼ 89.5%
18,9592024+8,260Profit-25,218Dividend2,0002025

NOLCA MED paid out €25,218 in dividends. That is 305% of the 2025 profit.

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Debts

€29,081 94% of the balance sheet
Suppliers 1%Taxes and wages 13%Other 87%

Liquidity

1.07 was 3.90 in 2024

Short-term debts rose from €3,780 to €29,081.

Filings

4 annual accounts 2 late
AprilJune31 JulyOctober2022202320242025

The 2025 accounts came in latest, 18 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as NOLCA MED has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for NOLCA MED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 22-12-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0794997746
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 22-12-2022 · Gazette deed
First establishment Faubourg de Namur 82, Nivelles
All 9 events

Official details

Source: KBO
Status
Active since 20-12-2022Normal situation
Activity
“Permettre aux actionnaires qui la composent,la pratique et l'organisation de la fonction de technologue…” (deed in French)From the articles, 2 activities1 activity on the establishment unit
Establishment unit
2.339.643.0671400 Nivelles, since 20-12-2022
Financial year end
31 December
Peppol
Reachable since 19-08-2026
Company details

Annual accounts 2025

€31,081▲ 36.7%
Filing
Filed on 18-08-2026
Financials

Insights on NOLCA MED

NOLCA MED files the micro format. That format states no turnover. The gross margin rose from €1,026 in 2022 to €20,616 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NOLCA MED

What is the company number of NOLCA MED?
The company number of NOLCA MED is 0794.997.746. The VAT number is the same number with BE in front: BE 0794.997.746.
Where is NOLCA MED based?
The registered office is at Faubourg de Namur 82, 1400 Nivelles.Company details
What is the legal form of NOLCA MED?
NOLCA MED is a private limited company (BV).
When was NOLCA MED founded?
NOLCA MED was founded on 20-12-2022.
Is NOLCA MED still active?
Yes, NOLCA MED is an active enterprise in the KBO register.
What is the turnover of NOLCA MED?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €20,616 and 7,100 comparable companies of the same size. It probably lies between €70,000 and €360,000. It is a rough estimate.Financials
Is NOLCA MED profitable?
In financial year 2025, NOLCA MED made a profit of €8,260.
Where can I find the annual accounts of NOLCA MED?
NOLCA MED filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NOLCA MED due?
NOLCA MED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.